Davis Jerel - Sep 12, 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role: Director
Signature: /s/ Rich Van Doren, Attorney-in-Fact
Stock symbol: KDNY
Transactions as of: Sep 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/14/2022, 04:53 PM
Previous filing: Aug 16, 2022
Next filing: Dec 13, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KDNY	Common Stock	Other	$0	-292K	-19.46%	$0.00	1.21M	Sep 12, 2022	See Footnote	F1, F2
transaction	KDNY	Common Stock	Other	$0	+2.88K		$0.00	2.88K	Sep 12, 2022	See Footnote	F3, F4
transaction	KDNY	Common Stock	Other	$0	-87K	-19.61%	$0.00	356K	Sep 12, 2022	See Footnote	F5, F6
transaction	KDNY	Common Stock	Other	$0	+4.69K	+163.03%	$0.00	7.57K	Sep 12, 2022	See Footnote	F4, F7
transaction	KDNY	Common Stock	Other	$0	-7.57K	-100%	$0.00^*	0	Sep 12, 2022	See Footnote	F4, F8
transaction	KDNY	Common Stock	Other	$0	+1.32K	+0.18%	$0.00	736K	Sep 12, 2022	Direct	F9
transaction	KDNY	Common Stock	Other	$0	-568K	-19.5%	$0.00	2.35M	Sep 12, 2022	See Footnote	F10, F11
transaction	KDNY	Common Stock	Other	$0	+11.4K		$0.00	11.4K	Sep 12, 2022	See Footnote	F12, F13
transaction	KDNY	Common Stock	Other	$0	-11.4K	-100%	$0.00^*	0	Sep 12, 2022	See Footnote	F13, F14
transaction	KDNY	Common Stock	Other	$0	+1.98K	+0.27%	$0.00	738K	Sep 12, 2022	Direct	F15
transaction	KDNY	Common Stock	Other	$0	+9.38K		$0.00	9.38K	Sep 12, 2022	See Footnote	F16, F17
transaction	KDNY	Common Stock	Other	$0	-9.38K	-100%	$0.00^*	0	Sep 12, 2022	See Footnote	F17, F18

Showing 1 to 12 of 12 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I, L.P. ("Versant Voyageurs I") to its partners.
F2	These securities are held of record by Versant Voyageurs I. Versant Voyageurs I GP Company is the general partner of Versant Voyageurs I. The Reporting Person, a member of the Issuer's board of directors, is a director of Versant Voyageurs I GP Company and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I. Each of Versant Voyageurs I GP Company and the Reporting Person disclaims beneficial ownership of the shares held by Versant Voyageurs I, except to the extent of their respective pecuniary interests therein.
F3	Represents a change in the form of ownership of Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP") by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Voyageurs I.
F4	Shares held by Versant Voyageurs I GP. The Reporting Person, a member of the Issuer's board of directors, is a partner of Versant Voyageurs I GP and may be deemed to share voting and dispositive power over the shares held by Versant Voyageurs I GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
F5	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel") to its partners.
F6	These securities are held of record by Versant I Parallel. Versant Voyageurs I GP is the general partner of Versant I Parallel. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant Voyageurs I GP. Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant I Parallel. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP, Versant Voyageurs I GP and the Reporting Person disclaims beneficial ownership of the shares held by Versant I Parallel, except to the extent of their respective pecuniary interests therein.
F7	Represents a change in the form of ownership of Versant Voyageurs I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant I Parallel.
F8	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Voyageurs I GP, to its partners.
F9	Represents a change in the form of ownership of the Reporting Person as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Voyageurs I.
F10	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VII, L.P. ("Versant VII") to its partners.
F11	These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. ("Versant Ventures VII GP") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC ("Versant Ventures VII GP-GP") is the general partner of Versant Ventures VII GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant Ventures VII GP-GP, Versant Ventures VII GP and the Reporting Person disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein.
F12	These securities are held of record by Versant VII. Versant Ventures VII GP, L.P. ("Versant Ventures VII GP") is the general partner of Versant VII, and Versant Ventures VII GP-GP, LLC ("Versant Ventures VII GP-GP") is the general partner of Versant Ventures VII GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VII. Each of Versant Ventures VII GP-GP, Versant Ventures VII GP and the Reporting Person disclaims beneficial ownership of the shares held by Versant VII, except to the extent of their respective pecuniary interests therein.
F13	Shares held by Versant Ventures VII GP. Versant Ventures VII GP-GP is the general partner of Versant Ventures VII GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP; however, each of Versant Ventures VII GP-GP and the Reporting Person disclaim beneficial ownership of the shares held by Versant Ventures VII GP, except to the extent of their respective pecuniary interests therein.
F14	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP to its partners.
F15	Represents a change in the form of ownership of the Reporting Person as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VII GP.
F16	Represents a change in the form of ownership of Versant Ventures VII GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VII GP.
F17	Shares held by Versant Ventures VII GP-GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant Ventures VII GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VII GP-GP; however, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
F18	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VII GP-GP to its members.